NO20060379L - Den polymorfe form av 4-[6-acetyl-3-[3-(4-acetyl-3-hydroksy-2-propylfenyltio)propoksy]-2-propylfenoksybutansyre - Google Patents
Den polymorfe form av 4-[6-acetyl-3-[3-(4-acetyl-3-hydroksy-2-propylfenyltio)propoksy]-2-propylfenoksybutansyreInfo
- Publication number
- NO20060379L NO20060379L NO20060379A NO20060379A NO20060379L NO 20060379 L NO20060379 L NO 20060379L NO 20060379 A NO20060379 A NO 20060379A NO 20060379 A NO20060379 A NO 20060379A NO 20060379 L NO20060379 L NO 20060379L
- Authority
- NO
- Norway
- Prior art keywords
- acetyl
- propylphenoxybutanoic
- propylphenylthio
- propoxy
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/601,862 US7064146B2 (en) | 2003-06-24 | 2003-06-24 | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| PCT/US2004/020154 WO2005000243A2 (en) | 2003-06-24 | 2004-06-24 | The polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butryric acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060379L true NO20060379L (no) | 2006-03-24 |
Family
ID=33539463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060379A NO20060379L (no) | 2003-06-24 | 2006-01-24 | Den polymorfe form av 4-[6-acetyl-3-[3-(4-acetyl-3-hydroksy-2-propylfenyltio)propoksy]-2-propylfenoksybutansyre |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7064146B2 (ko) |
| EP (1) | EP1636176A4 (ko) |
| JP (2) | JP5518280B2 (ko) |
| KR (1) | KR101120408B1 (ko) |
| CN (1) | CN1812968B (ko) |
| BR (1) | BRPI0411973A (ko) |
| CA (1) | CA2530583C (ko) |
| NO (1) | NO20060379L (ko) |
| NZ (1) | NZ544319A (ko) |
| RU (1) | RU2317979C2 (ko) |
| WO (1) | WO2005000243A2 (ko) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7060854B2 (en) * | 2003-06-24 | 2006-06-13 | Medicinova, Inc. | Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid |
| US7064146B2 (en) * | 2003-06-24 | 2006-06-20 | Medicinova, Inc. | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| NZ550809A (en) | 2004-04-27 | 2010-07-30 | Medicinova Inc | Phenoxyalkycarboxylic acid derivatives in the treatment of inflammatory diseases |
| US8835499B2 (en) | 2011-12-08 | 2014-09-16 | Medicinova, Inc. | Method of treating non-alcoholic fatty liver disease and steatohepatitis |
| US8962687B2 (en) | 2012-12-05 | 2015-02-24 | Medicinova, Inc. | Method of treating liver disorders |
| KR102352728B1 (ko) | 2013-07-25 | 2022-01-18 | 메디시노바, 인크. | 트리글리세라이드, 총 콜레스테롤, 및 저밀도 지단백질의 혈중농도를 감소시키는 방법 |
| US20150321989A1 (en) * | 2014-05-08 | 2015-11-12 | Medicinova, Inc. | Method of treating idiopathic pulmonary fibrosis |
| US9346754B2 (en) | 2014-05-08 | 2016-05-24 | Medicinova, Inc. | Method of treating advanced non-alcoholic steatohepatitis |
| EP3148523B1 (en) | 2014-06-02 | 2023-08-16 | MediciNova, Inc. | Method of inhibiting or treating fibrosis |
| AU2015306683B2 (en) * | 2014-08-25 | 2021-11-25 | Societe Des Produits Nestle S.A. | Egg protein formulations and methods of manufacture thereof |
| US20160220710A1 (en) * | 2015-01-30 | 2016-08-04 | The Regents Of The University Of Michigan | Compositions and methods for delivering pharmaceutical agents |
| JP2024522030A (ja) | 2021-05-28 | 2024-06-10 | メディシノバ・インコーポレイテッド | フェノキシアルキルカルボン酸誘導体、およびトリグリセリドレベルを低下させることにおけるその使用 |
| WO2024117173A1 (ja) * | 2022-11-30 | 2024-06-06 | 花王株式会社 | 痒みの予防又は改善剤 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5858146A (ja) | 1981-10-05 | 1983-04-06 | Tanabe Seiyaku Co Ltd | 速放性マイクロカプセル |
| US4710384A (en) | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
| JPH07116125B2 (ja) * | 1988-03-07 | 1995-12-13 | 杏林製薬株式会社 | フェノキシアルキルカルボン酸誘導体及びその製造法 |
| US4985585A (en) * | 1988-03-07 | 1991-01-15 | Kyorin Pharmaceutical Co., Ltd. | Phenoxyalkylcarboxylic acid derivatives and process for their preparations |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| JPH06345682A (ja) * | 1993-06-11 | 1994-12-20 | Kyorin Pharmaceut Co Ltd | カルボン酸誘導体 |
| JP3773064B2 (ja) * | 1994-09-13 | 2006-05-10 | 杏林製薬株式会社 | フェノキシアルキルカルボン酸誘導体の製造法 |
| US5639475A (en) | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
| JPH1179985A (ja) | 1997-09-01 | 1999-03-23 | Kyorin Pharmaceut Co Ltd | 喘息治療用の粉末吸入剤 |
| US7060854B2 (en) * | 2003-06-24 | 2006-06-13 | Medicinova, Inc. | Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid |
| US7064146B2 (en) * | 2003-06-24 | 2006-06-20 | Medicinova, Inc. | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
-
2003
- 2003-06-24 US US10/601,862 patent/US7064146B2/en not_active Expired - Lifetime
-
2004
- 2004-06-24 CA CA2530583A patent/CA2530583C/en not_active Expired - Fee Related
- 2004-06-24 KR KR1020057024889A patent/KR101120408B1/ko active IP Right Grant
- 2004-06-24 WO PCT/US2004/020154 patent/WO2005000243A2/en active Application Filing
- 2004-06-24 JP JP2006517585A patent/JP5518280B2/ja not_active Expired - Lifetime
- 2004-06-24 EP EP04776980A patent/EP1636176A4/en not_active Withdrawn
- 2004-06-24 BR BRPI0411973-8A patent/BRPI0411973A/pt not_active IP Right Cessation
- 2004-06-24 RU RU2006101871/04A patent/RU2317979C2/ru not_active IP Right Cessation
- 2004-06-24 NZ NZ544319A patent/NZ544319A/en not_active IP Right Cessation
- 2004-06-24 CN CN200480017934.0A patent/CN1812968B/zh not_active Expired - Lifetime
-
2005
- 2005-12-29 US US11/319,272 patent/US7365224B2/en not_active Expired - Lifetime
-
2006
- 2006-01-24 NO NO20060379A patent/NO20060379L/no not_active Application Discontinuation
-
2008
- 2008-04-21 US US12/106,939 patent/US7728169B2/en not_active Expired - Lifetime
-
2013
- 2013-12-24 JP JP2013265114A patent/JP2014097989A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ544319A (en) | 2008-12-24 |
| US20080292698A1 (en) | 2008-11-27 |
| JP5518280B2 (ja) | 2014-06-11 |
| WO2005000243A2 (en) | 2005-01-06 |
| RU2317979C2 (ru) | 2008-02-27 |
| BRPI0411973A (pt) | 2006-08-29 |
| US20060135604A1 (en) | 2006-06-22 |
| JP2007524624A (ja) | 2007-08-30 |
| JP2014097989A (ja) | 2014-05-29 |
| WO2005000243A3 (en) | 2005-04-28 |
| CN1812968A (zh) | 2006-08-02 |
| CA2530583A1 (en) | 2005-01-06 |
| US7064146B2 (en) | 2006-06-20 |
| KR101120408B1 (ko) | 2012-03-15 |
| US7365224B2 (en) | 2008-04-29 |
| EP1636176A2 (en) | 2006-03-22 |
| CA2530583C (en) | 2010-08-10 |
| KR20060030484A (ko) | 2006-04-10 |
| US7728169B2 (en) | 2010-06-01 |
| CN1812968B (zh) | 2016-07-27 |
| RU2006101871A (ru) | 2006-07-27 |
| US20040266878A1 (en) | 2004-12-30 |
| EP1636176A4 (en) | 2010-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060379L (no) | Den polymorfe form av 4-[6-acetyl-3-[3-(4-acetyl-3-hydroksy-2-propylfenyltio)propoksy]-2-propylfenoksybutansyre | |
| NO20065719L (no) | I det vesentlige rene 2-{[2-(2-metylamino-pyrimidin-4-yl)-1H-indol-5-karbonyl]-amlno}-3-(fenylpyridin-2-yl-amino)-propionsyre som en IkB kinaseinhibitor. | |
| NO20080789L (no) | 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid | |
| NO330968B1 (no) | Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| NO20054852L (no) | GFAT inhibitorer | |
| MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
| BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
| NO20006221L (no) | Fremgangsmåte for bekjempelse av skadedyr | |
| EP1482924A2 (en) | Cathepsin cysteine protease inhibitors | |
| ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
| PE20060298A1 (es) | Derivados de acido carboxilico de bencimidazolona | |
| NO20074188L (no) | Prosess for fremstilling av montelukast og mellomprodukter for det | |
| EA200400491A1 (ru) | Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции | |
| NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
| NO20063268L (no) | Fremgangsmate til fremstilling av 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-metoksybenzyl)quinuklidin-3-amin | |
| NO20080738L (no) | Fremgangsmater for neurobeskyttelse | |
| CY1108351T1 (el) | Παραγωγα κυκλοαλκυλικης λακταμης ως αναστολεις της 11-βητα-υδροξυστεροειδους αφυδρογονασης ι | |
| DK1763534T3 (da) | Nye 2-substituerede D-homo-estra-1,3,5(10)-triener som inhibitorer af 17beta-hydroxysteroiddehydrogenasen type 1 | |
| NO20013684L (no) | Substituerte fenetylaminderivater | |
| US20060166966A1 (en) | 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis | |
| NO20063111L (no) | Fremgangsmate for fremstilling av tiazolpyrimidiner | |
| WO2005000242A3 (en) | Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]butyric acid | |
| NO20073330L (no) | Sulfanylsubstituerte fenylmetanoner som glycintransportor 1 (glyt-1) inhibitorer for behandling av nevrologiske og nevropsykiatriske forstyrrelser | |
| NO20062965L (no) | NK-1-Reseptorantagonister | |
| SE0400410D0 (sv) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |